| KDM1 is a novel therapeutic target for the treatment of gliomas GR Sareddy, BC Nair, SK Krishnan, VK Gonugunta, Q Zhang, T Suzuki, ... Oncotarget 4 (1), 18, 2013 | 73 | 2013 |
| Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers GV Raj, GR Sareddy, S Ma, TK Lee, S Viswanadhapalli, R Li, X Liu, ... Elife 6, e26857, 2017 | 50 | 2017 |
| Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response BC Nair, SR Krishnan, GR Sareddy, M Mann, B Xu, M Natarajan, P Hasty, ... Cell Death & Differentiation 21 (9), 1409-1418, 2014 | 37 | 2014 |
| Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells SR Krishnan, BC Nair, GR Sareddy, SS Roy, M Natarajan, T Suzuki, ... Breast cancer research and treatment 150, 487-499, 2015 | 30 | 2015 |
| Nanotherapeutics in cancer prevention, diagnosis and treatment SR Krishnan, SK George Pharmacol. Ther, 2014 | 23 | 2014 |
| Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance VK Gonugunta, GR Sareddy, SR Krishnan, V Cortez, SS Roy, RR Tekmal, ... Molecular cancer therapeutics 13 (6), 1578-1588, 2014 | 19 | 2014 |
| PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling GR Sareddy, UP Pratap, S Viswanadhapalli, PP Venkata, BC Nair, ... Neuro-Oncology Advances 1 (1), vdz042, 2019 | 13 | 2019 |
| Emerging significance of estrogen cancer coregulator signaling in breast cancer. M Mann, S Krishnan, RK Vadlamudi Minerva ginecologica 64 (1), 75-88, 2012 | 13 | 2012 |
| A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer KA Altwegg, S Viswanadhapalli, M Mann, D Chakravarty, S Krishnan, ... Cancer research 82 (20), 3830-3844, 2022 | 8 | 2022 |
| Targeting of PELP1 in cancer therapy RK Vadlamudi, M Monica, S Krishnan, GR Sareddy US Patent 10,682,388, 2020 | 2 | 2020 |
| Therapeutic efficacy of ERβ agonists on ovarian cancer GR Sareddy, JE Chavez, H Salazar, M Mann, J Hernandez, SR Krishnan, ... Cancer Research 74 (19_Supplement), 606-606, 2014 | 2 | 2014 |
| S-equol, an estrogen receptor β agonist, inhibits tumor growth and progression of breast cancer C Samayoa, NK Krishnegowda, SR Krishnan, RK Vadlamudi, RR Tekmal Cancer Research 74 (19_Supplement), 622-622, 2014 | 1 | 2014 |
| Neuro-Oncology Advances GR Sareddy, UP Pratap, S Viswanadhapalli, PP Venkata, BC Nair, ... | | 2019 |
| ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ... Cancer Research 76 (14_Supplement), 860-860, 2016 | | 2016 |
| ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ... CANCER RESEARCH 76, 2016 | | 2016 |
| Abstract S3-04: ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ... Cancer Research 76 (4_Supplement), S3-04-S3-04, 2016 | | 2016 |
| Abstract B08: ESR1 coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy-resistant breast cancer RK Vadlamudi, GR Sareddy, S Viswanadhapalli, TK Lee, SH Ma, WR Lee, ... Molecular Cancer Research 14 (2_Supplement), B08-B08, 2016 | | 2016 |
| Targeting error-prone alternative nonhomologous end joining (A-NHEJ) DNA repair pathway to treat ESR1-mediated therapy resistance S Krishnan, B Nair, G Sareddy, M Mann, RK Vadlamudi Cancer Research 75 (15_Supplement), 2854-2854, 2015 | | 2015 |
| PELP1 promotes DNA double-strand break repair via alternative-NHEJ: Implications in therapy resistance SR Krishnan, BC Nair, GR Sareddy, M Mann, RK Vadlamudi Cancer Research 74 (19_Supplement), 2731-2731, 2014 | | 2014 |
| Novel role of proto-oncogene PELP1 in A-NHEJ pathway of double strand break repair: Implications for treatment of hormonal therapy resistance SR Krishnan, BC Nair, M Mann, GR Saareddy, J Stark, V Gorbunova, ... CANCER RESEARCH 73, 2013 | | 2013 |
